Molecular Oncology has now become an essential part of cancer diagnosis and treatment. Identification of genetic changes in hereditary cancer syndromes such as neurofibromatosis, Lynch syndrome, hereditary breast and ovarian cancer syndrome are now essential part of routine diagnosis tests in cancer care worldwide. Also, specific molecular diagnostics tests are required now for selecting chemotherapeutic regimen in certain cancers such as adenocarcinomas of lung for better survival rate and quality of life. The molecular oncology diagnostics requires a streamlined work-flow starting from good quality histopathological examination, leading on to tailor-made and affordable molecular biology assays, analysis that ultimately translatable into clinically meaningful interpretations. Experts in oncology, pathology and molecular biology departments in Amrita Institute of Medical Sciences have joined hands to make this possible in a seamless way to proliferate an efficient and advanced genetic and genomic level variance detection in cancer diagnostics. Please see the following list of tests we have currently introduced in Amrita Molecular Oncology Laboratory.
Many new research studies have been initiated with the co-ordination of all the clinical, and non-clinical departments. For e.g. Amrita Phakomatoses Clinic. A specialized clinic to screen patients who have been suspected to have hereditary phakomatoses syndromes causing multiple tumors in the brain and spinal cord and other nervous system related regions of the body. The disorders include neurofibromatosis type 1-, type 2, von Hippel Lindau syndrome, Gorlin syndrome etc. The clinic is a coordinated effort of Neurosurgery, Neurology, Urology, GI surgery, Endocrinology, Ophthalmology, Paediatric Genetics and Molecular Diagnostics Division of Medical Oncology.
Medical Oncology, Molecular Diagnostics Division;
Amrita Institute of Medical Sciences
AIMS Ponekkara P.O. Kochi, India 682041
Phone - Office: (+91) 484 285 2250; Mobile: (+91) 703 402 8814